Ransi Somaratne

Equibles does not estimate personal net worth.

Get an email with a short summary when Absci Corp publishes a filing, an earnings call transcript or a press release.

About Ransi Somaratne

Absci Corp reported in an 8-K filed March 6, 2026 that Ransi Somaratne was appointed Chief Medical Officer, effective March 3, 2026. Ransi Somaratne has spoken on 1 earnings call across 1 company, most recently for Absci Corp on May 7, 2026. Absci Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Absci Corp includes Sean McClain (CEO and Board Member), Zachariah Jonasson (CFO), Zachariah Jonasson, Ph.D. (CFO) and 7 others.

“On March 3, 2026, the Company issued a press release announcing Dr. Busch's retirement and the appointment of Ransi Somaratne, M.D., as the Company's Chief Medical Officer, effective as of March 3, 2026.”

Absci Corp Form 8-K, filed March 6, 2026 · Read the filing

Ransi Somaratne on recent calls

“As Sean mentioned, we are pleased to share that our ongoing Phase 1-2A headline trial for ABS-201 is progressing well and tracking according to plan. As a reminder, this trial is a randomized, double-blind, placebo-controlled study.”

Board Member, Absci Corp Q1 FY2026 Earnings Call · May 7, 2026